Adiponectin independently predicts metabolic syndrome in overweight Latino youth

Gabriel Shaibi, Martha L. Cruz, Marc J. Weigensberg, Claudia M. Toledo-Corral, Christianne J. Lane, Louise A. Kelly, Jaimie N. Davis, Corinna Koebnick, Emily E. Ventura, Christian K. Roberts, Michael I. Goran

Research output: Contribution to journalArticle

71 Scopus citations


Context: Adiponectin may be important in the pathogenesis of insulin resistance and the metabolic syndrome in youth. Objective: The objective of the study was to determine the unique effect of adiponectin on the metabolic syndrome in overweight Latino youth. Participants: Participants included 175 overweight children (aged 11.1 ± 1.7 yr, body mass index percentile 97.3 ± 2.9) with a family history of type 2 diabetes. Methods: Metabolic syndrome was defined according to a pediatric adaptation of the Adult Treatment Panel III report and included dyslipidemia, abdominal obesity, elevated blood pressure, and prediabetes (impaired fasting glucose or impaired glucose tolerance from a 2-h oral glucose tolerance test). Body composition was estimated via dual-energy x-ray absorptiometry, insulin sensitivity was quantified by the frequently sampled iv glucose tolerance test, visceral fat was measured using magnetic resonance imaging, and adiponectin was determined in fasting serum. Results: In simple linear regression, adiponectin was significantly and inversely related to systolic blood pressure (P < 0.05), waist circumference (P < 0.001), triglycerides (P < 0.001), and 2-h glucose levels (P < 0.05) and positively related to high-density lipoprotein-cholesterol (P < 0.001). In multiple linear regression, adiponectin was significantly related to triglycerides (P < 0.01) and high-density lipoprotein-cholesterol (P < 0.01) independent of age, gender, Tanner stage, body composition, and insulin sensitivity. Analyses of covariance established that adiponectin levels were approximately 25% higher in healthy overweight youth, compared with those with the metabolic syndrome (12.5 ± 3.5 vs. 9.4 ± 2.8 μg/ml; P < 0.05). In multiple logistic regression, adiponectin was a significant independent predictor of the metabolic syndrome, even after adjustment for confounders including insulin sensitivity and visceral fat. Conclusions: Hypoadiponectinemia is an independent biomarker of the metabolic syndrome, and thus, adiponectin may play a role in the pathophysiology of the disorder in overweight youth.

Original languageEnglish (US)
Pages (from-to)1809-1813
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Issue number5
StatePublished - May 2007

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Dive into the research topics of 'Adiponectin independently predicts metabolic syndrome in overweight Latino youth'. Together they form a unique fingerprint.

  • Cite this

    Shaibi, G., Cruz, M. L., Weigensberg, M. J., Toledo-Corral, C. M., Lane, C. J., Kelly, L. A., Davis, J. N., Koebnick, C., Ventura, E. E., Roberts, C. K., & Goran, M. I. (2007). Adiponectin independently predicts metabolic syndrome in overweight Latino youth. Journal of Clinical Endocrinology and Metabolism, 92(5), 1809-1813.